Literature DB >> 13365063

Factors influencing conversion of chronic atrial fibrillation with special reference to serum quinidine concentration.

R E BALL, M SOKOLOW.   

Abstract

Entities:  

Keywords:  AURICULAR FIBRILLATION/therapy; QUINIDINE/therapeutic use

Mesh:

Substances:

Year:  1956        PMID: 13365063     DOI: 10.1161/01.cir.14.4.568

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  32 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  THE PROGNOSIS OF ATRIAL FIBRILLATION FOLLOWING MITRAL VALVOTOMY.

Authors:  V R BLOOM
Journal:  Br Heart J       Date:  1963-09

3.  VENTRICULAR FIBRILLATION IN MYXOEDEMA HEART DISEASE WITH SPONTANEOUS REVERSION.

Authors:  R W MARCUSON
Journal:  Br Heart J       Date:  1965-05

4.  Ouinidine therapy after mitral valvotomy.

Authors:  C P ABER
Journal:  Thorax       Date:  1962-09       Impact factor: 9.139

5.  Quinidine: arterial, venous, coronary sinus and myocardial concentrations.

Authors:  L SCHERLIS; L F GONZALEZ; S P BESSMAN
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

6.  Comparison of quinidine plasma concentration curves following oral administration of some short- and long-acting formulations.

Authors:  G M Frigo; E Perucca; M Teggia-Droghi; G Gatti; A Mussini; J Salerno
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

7.  Dose-dependence of the pharmacokinetics of quinidine.

Authors:  P Bolme; U Otto
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

Review 8.  Therapeutic drug monitoring: antiarrhythmic drugs.

Authors:  T J Campbell; K M Williams
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

9.  Comparative bioavailability study of three sustained release quinidine formulations.

Authors:  W A Mahon; J S Leeder; M M Brill-Edwards; J Correia; S M MacLeod
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

10.  THE RELATIONSHIP OF DOSAGE SCHEDULE TO THE BLOOD LEVEL OF QUINIDINE, USING ALL AVAILABLE QUINIDINE PREPARATIONS.

Authors:  W M GOLDBERG; S G CHAKRABARTI
Journal:  Can Med Assoc J       Date:  1964-11-07       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.